1. Structural Diversity using Hyp 'Customizable Units' : Proof‐of‐Concept Synthesis of Sansalvamide‐Related Antitumoral Peptides
- Author
-
Irene Vergara, Alicia Boto, Ivan Romero-Estudillo, Fernando Cuevas, Mario Ordóñez, Carlos Javier Saavedra, Consejo Nacional de Ciencia y Tecnología (México), Ministerio de Economía y Empresa (España), Ministerio de Ciencia e Innovación (España), and Biosigma
- Subjects
Antitumor agents ,010405 organic chemistry ,Chemistry ,Organic Chemistry ,Library science ,Structural diversity ,010402 general chemistry ,01 natural sciences ,0104 chemical sciences ,Customizable units ,Work (electrical) ,Proof of concept ,Molecular diversity ,Domino reactions ,Physical and Theoretical Chemistry ,Peptides ,Selective modification - Abstract
The potential of “customizable units” to generate structural diversity for biological screenings is highlighted in this proof‐of‐concept synthesis of new peptides related to the potent antitumoral Sansalvamide A. Using L‐4‐hydroxyproline (Hyp) as a customizable unit in a linear parent peptide, an improved procedure for selective peptide modification was developed. A divergent Hyp scission‐reductive amination process was carried out, affording five linear peptides with cationic residues, and notably, an N‐alkyl moiety that affected the conformation of the peptide. After two steps (saponification and macrocyclization), sixteen differently N1‐substituted linear and cyclic peptides were obtained. For the first time, the activity of the linear and cyclic compounds was compared. Not only some linear analogs but also cyclic compounds with scarcely studied cationic residues were active against MCF7 breast cancer line. Thus, the structural diversity generated from customizable units can be valuable in drug discovery., This work was partly financed by the Consejo Nacional de Ciencia y Tecnología (CONACYT, Mexico) through project 2015‐01‐807, and by MINECO‐MCIU (Spain) with European Social Funds (ESF), through Programme Plan Estatal I+D‐RETOS (project SAF‐2013‐48399‐R). C. J. S. received a postdoctoral contract from the Torres Quevedo Programme (PTQ15‐07923) by MINECO/Min. Science and Innovation, cofinanced by BIOSIGMA SL. Finally, I.R−E. and F.C. thank CONACYT for Catedra contract 942 and predoctoral grant 305283 respectively.
- Published
- 2021
- Full Text
- View/download PDF